Seah H. Lim, M.D., Ph.D. 13D and 13G filings for Emmaus Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 11:00 am Sale |
2024-12-31 | 13G | Emmaus Life Sciences, Inc. EMMA |
Seah H. Lim, M.D., Ph.D. | 4,147,426 6.500% |
-439,200 (-9.58%) |
Filing |
| 2023-12-22 5:30 pm Purchase |
2023-12-18 | 13G | Emmaus Life Sciences, Inc. EMMA |
Seah H. Lim, M.D., Ph.D. | 4,586,626 7.400% |
4,586,626 (New Position) |
Filing |